Effect of Myrtus communis on proteinuria of type 2 diabetic patients

Effect of Myrtus communis herbal syrup on proteinuria of type 2 diabetic patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180610040049N8

Enrollment

Registered

2022-01-30

Start date

2022-02-03

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetic patients. Diabetes mellitus due to underlying condition with diabetic nephropathy

Interventions

Intervention 1: "Intervention group:" This group is given Mort syrup. Mort syrup is made from the myrtle plant, which is a type of shrub. Total extract of this plant is used. The dose is 120 mg / kg.

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Type 2 diabetic patients with proteinuria Absence of serious heart disease (heart attack, etc.) in the last 6 months Absence of kidney failure stage 3

Exclusion criteria

Exclusion criteria: Allergy to herbal medicines Patient's willingness to use other therapies

Design outcomes

Primary

Measure	Time frame
Proteinuria rate. Timepoint: One day before the intervention and one day after the intervention is measured. Method of measurement: By biochemical test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeied Amirhosein Latifi

Arak University of Medical Sciences

seiedalatifi@yahoo.com+98 86 3417 3601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026